Lectures and talks at scientific conferences

Pound P.
‘Breaking the lock-in to animal research within academia’. 11th World Congress on Alternatives and Animal Use in the Life Sciences, 2 September 2021. Presentation
Ram R.
‘New Approach Methodologies Funding and Regulation’. 11th World Congress on Alternatives and Animal Use in the Life Sciences, 30 August 2021. Presentation
Turner J.
‘Overcoming data availability obstacles in the way of evidence-based toxicology’. EBTC Scientific Symposium #4, 14 July 2021 Slides
Turner J.
‘Developing Methods and Technologies to Ensure Safe and Effective Medicines’. Westminster Health Forum meeting, 1 April 2021 Presentation.
Turner J.
‘Developing Methods and Technologies to Ensure Safe and Effective Medicines’. Westminster Health Forum meeting, 7 August 2020 Presentation.
Kenna, G.
‘Human-relevant models are needed to understand and treat human COVID-19 disease’. PCRM’s Congressional hearing “Confronting COVID-19: A Briefing on Prioritizing Human-Based Research, 7 July 2020 Presentation
Pound P.
Seminar: ‘Towards a new ethics of animal research.’ Centre for Ethics in Medicine, University of Bristol, 13 February 2020. Towards new ethics of animal research
Pound P.
Invited keynote lecture: ‘Are researchers moving away from animal models as a result of poor translation in the field of stroke? An analysis of opinion papers’. Symposium ‘After Translational Strategies’, Utrecht University, Utrecht, Netherlands, 27 November 2019. presentation for symposium
Pound P, Ram R.
Are researchers moving away from animal models as a result of poor translation in the field of stroke? European Society for Alternatives to Animal Testing (EUSAAT) Congress, Linz, Austria, 10-13 October 2019.analysis of opinion papers in stroke Pandora Pound
Turner J.
Replacing animal tests to improve safety for humans. Conference to launch book ‘Animal experimentation: Working towards a paradigm change, London, UK, March 8th 2019. Open access book:
Animal Experimentation: Working Towards a Paradigm Change

Kenna, G.
Overcoming obstacles to human-relevant science. WIST 2nd Congress: Science instead of animals. Cologne, Germany, October 27, 2018

Kenna, G.
Pharmacokinetics and ADME. ACT Course on Practical Application of Toxicology in Drug Development, 2018. Cambridge, UK. July 23, 2018 ACT_Kenna_2018
Kenna, G.
Pharmacokinetics and ADME. ACT Course on Practical Application of Toxicology in Drug Development, 2017. Cambridge, UK. July 19, 2017
Kenna, G.
Integrating DILI Hazards to Predict Toxicity of Drug Candidates. Assessment and Management of Human Risk in the Pharmaceutical Industry. 21st North American ISSX Meeting. Rhode Island, USA. September 24, 2017 ISSX21_Kenna_2017
Kenna, G.
How non-animal approaches can aid the design and selection of safe drugs. Applied Toxicology Modular MSc Course. Guildford UK. November 11, 2017 Surrey_Kenna_2017
Kenna, G.
BSEP inhibition and Drug Induced Liver Injury. SOLVO ‘Meet the Experts: The Transporter Conference. Budapest, Hungary. May 12, 2016 SOLVO_GK slides_09052016
Kenna, G.
Drug induced Liver Injury (DILI): What is the Problem? 11th International ISSX Meeting. Busan, South Korea. June 12, 2016 ISSX_2016_KennaDILI_1
Kenna, G.
Integrating DILI hazards enables prediction, assessment and management of human risk. 11th International ISSX Meeting. Busan, South Korea, June 12, 2016 ISSX_2016_KennaDILI_2
Kenna, G.
Pharmacokinetics and ADME ACT Course on Practical Application of Toxicology in Drug Development, 2016. Cambridge, UK. July 13, 2016 ACT_2016_GK slides_18052016
Kenna, G.
Current trends in BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury. Recommendations to the regulatory agencies concerning BSEP screening in drug discovery and development. PSTC global webinar. July 14, 2016 BSEP_Webinar_Kenna_2016
Kenna, G.
Regulating Chemical Safety – the future for animal use. How understanding drug toxicities can aid human chemical safety assessment without using animals. The Lush Prize Conference 2016. London, UK. November 10, 2016 Lush_2016_Kenna
Kenna, G.
Integrating data from multiple in vitro methods enable prediction of serious human adverse drug reactions. World Preclinical Congress Europe. Lisbon, Portugal. November 16, 2016 WPC_GK_28102016
15 minute presentation by Dr Bob Coleman at Horizons in Human Cells conference, Edinburgh, May 2014: “Humanising Drug Safety Testing”
24 minute presentation by Dr Bob Coleman at American College of Toxicology annual meeting, San Antonio, Texas, 4 November 2013:
Ensuring safety and efficacy in new medicines – humanising the process
Slide presentation by Dr Bob Coleman at Linz University, Austria, 17th September 2013: “Humanising Toxicity Testing in the 21st Century”.
Share
Follow Us

Latest Blog Posts

World Liver Day: Human-relevant research is needed into liver disease and Drug Induced Liver Injury (DILI)

By Rebecca Ram This month marks World Liver Day (held every year on 19 Apr) to raise awareness about diseases of the second largest organ in the body. After the brain, the liver is the most complex organ and is vital to the efficient control of the gastrointestinal (digestive) system. Liver diseases account for approximately […]

New Approach Methodologies in COVID-19: systematic review into the neurological effects of SARS-CoV-2 infection presented at SOT (Society of Toxicology) Congress 2022

By Rebecca Ram Launched nearly two years ago, the CIAO project (Modelling the Pathogenesis of COVID-19 using the Adverse Outcome Pathway Framework) involves the collaboration of scientific experts to identify the chemical and biological events involved in the body’s response to the SARS-CoV-2 virus. Expert working groups are established across a number of areas, for […]